Cargando…

Will immune therapy cure acute myeloid leukemia?

Detalles Bibliográficos
Autor principal:	Gale, Robert Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974985/ https://www.ncbi.nlm.nih.gov/pubmed/35402798 http://dx.doi.org/10.1097/BS9.0000000000000024

Ejemplares similares

Can Immune Therapy Cure Acute Myeloid Leukemia?
por: Gale, Robert Peter
Publicado: (2023)

Lessons learned from therapy-related acute myeloid leukemia
por: Kayser, Sabine
Publicado: (2022)

Immune control in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2017)

ARQ531: the therapy that targets multiple pathways in acute myeloid leukemia
por: Hellmich, Charlotte, et al.
Publicado: (2020)

Is allogeneic transplantation the preferred therapy for older patients with acute myeloid leukemia?
por: Ganser, Arnold
Publicado: (2022)

Toward the Cure of Acute Lymphoblastic Leukemia in Children in China
por: Chen, Si-Liang, et al.
Publicado: (2021)

Fusion genes in acute myeloid leukemia: do acute myeloid leukemia diagnostics need to fuse with RNA-sequencing?
por: Thol, Felicitas
Publicado: (2022)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Targeted Chronic Myeloid Leukemia Therapy: Seeking a Cure
por: Fausel, Christopher
Publicado: (2007)

BETing on rational combination therapy in mutant FLT3 acute myeloid leukemia
por: Stone, Richard M.
Publicado: (2020)

The Important Role of Immunotherapies in Acute Myeloid Leukemia
por: Greiner, Jochen
Publicado: (2019)

Current treatment for pediatric acute myeloid leukemia
por: Im, Ho Joon
Publicado: (2018)

Pulling the Pin on NPMc(+) acute myeloid leukemia
por: Kats, Lev M.
Publicado: (2021)

Check(point) or checkmate for acute myeloid leukemia?
por: Niyongere, Sandrine, et al.
Publicado: (2021)

Immune therapy: a new therapy for acute myeloid leukemia
por: Tian, Chen, et al.
Publicado: (2022)

Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Kapoor, Sargam, et al.
Publicado: (2021)

Acute Myeloid Leukemia: Advanced Practice Management From Presentation to Cure
por: Beaton, Meredith, et al.
Publicado: (2020)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
por: Stemler, Jannik, et al.
Publicado: (2022)

Chronic lymphocytic leukemia in China
por: Gale, Robert Peter
Publicado: (2022)

Expanding dasatinib beyond KIT in acute myeloid leukemia
por: Welch, John S.
Publicado: (2020)

Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia
por: Palmieri, Raffaele, et al.
Publicado: (2022)

miRNAs as prognostic predictors in acute myeloid leukemia
por: Machado-Neto, João Agostinho, et al.
Publicado: (2023)

Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
por: Russo, Domenico, et al.
Publicado: (2020)

Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects
por: Gambacorta, Valentina, et al.
Publicado: (2019)

The changing face of acute myeloid leukemia therapeutics in the elderly population
por: Daver, Naval, et al.
Publicado: (2015)

NOX2: a determinant of acute myeloid leukemia survival
por: Jones, Courtney L.
Publicado: (2022)

Unbiased decision-making for acute myeloid leukemia still needed
por: Eisfeld, Ann-Kathrin
Publicado: (2022)

Disrupting autophagy in FLT3-mutant acute myeloid leukemia
por: Grant, Steven
Publicado: (2022)

Targeted Therapies and Druggable Genetic Anomalies in Acute Myeloid Leukemia: From Diagnostic Tools to Therapeutic Interventions
por: Lanza, Francesco, et al.
Publicado: (2021)

To live is well but to live well is better: venetoclax combination therapy and quality-of-life in acute myeloid leukemia
por: Gangat, Naseema, et al.
Publicado: (2022)

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia
por: Li, Bing, et al.
Publicado: (2014)

CLAG-M with dose-escalated mitoxantrone for adults with acute myeloid leukemia
por: Halpern, Anna B., et al.
Publicado: (2018)

An exciting RXRA mutant revives interest in retinoids for acute myeloid leukemia
por: Qiu, Fang, et al.
Publicado: (2021)

Proteomics: a new era in pediatric acute myeloid leukemia research
por: Lamba, Jatinder K., et al.
Publicado: (2022)

Delving the depths of measurable residual disease negativity in acute myeloid leukemia
por: Freeman, Sylvie D.
Publicado: (2022)

A novel approach to overcome drug resistance in acute myeloid leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Reductive carboxylation of glutamine as a potential target in acute myeloid leukemia
por: Roma, Alessia, et al.
Publicado: (2023)

Descriptive and Functional Genomics in Acute Myeloid Leukemia (AML): Paving the Road for a Cure
por: Pasquer, Hélène, et al.
Publicado: (2021)

Advances in targeted therapy for acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p10qe7k4vsi9fo5bcrq8g5daam